Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179049 · ClinicalTrials.gov registry record
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
A clinical trial of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation, sponsored by Vanderbilt University.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00179049 is a study of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation that has completed, run by Vanderbilt University. The registered enrollment target is 100 participants, below the 135-participant average among 36 other Graft Vs Host Disease trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00179049, a study of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179049
The ClinicalTrials.gov registry entry for NCT00179049 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 36 other Graft Vs Host Disease trials with a reported enrollment target (26% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Graft Vs Host Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00179049 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00179049 about?
NCT00179049 is a clinical study titled "Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant". The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.
What is the current status of trial NCT00179049?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2003-04. Estimated completion is 2008-04.
What conditions does trial NCT00179049 study?
This clinical trial studies the following conditions: Graft Vs Host Disease, Hematopoietic Stem Cell Transplantation.
Who is sponsoring clinical trial NCT00179049?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00179049 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graft Vs Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
RECRUITING
-
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
RECRUITING · NA
-
IS-free Treg HaploHCT
RECRUITING · Phase 1
-
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
RECRUITING · Phase 2
-
A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
RECRUITING · Phase 1
-
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
RECRUITING · Phase 2
Explore more on PlainTrial
Graft Vs Host Disease
All registered trials for this condition
Hematopoietic Stem Cell Transplantation
All registered trials for this condition
Tennessee
All trials with a study site in Tennessee
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.